expanded clinical service options for physician practices allergy … derm allergy handouts...

Expanded Clinical Service Options for Physician Practices

Allergy and Dermatology Services

Confidential

Table of Contents

S�i� a�d Aergy Ce�ters �f A�erica� ��C�Pr�vidi�g c��passi��ate a�d patie�t ce�tered care�

Confidential

• Introduction to Skin and Allergy Centers of America (SACA)

• Executive Team

• Mission

• Business Model Overview

• Allergy Service Description and Business Model

• Dermatology Service Description and Business Model

• Summary and Next Steps

• Discussion

2

Introduction to Skin and Allergy Centers of America (SACA)

Team

• Richard C. Wright, Scott Sumrall, Abdul Ibrahim, Benjamin Hayes, PhD MD, Ryan Sullivan MD,

Richard Becker MD, Phyllis Arnold

• Seasoned healthcare professionals with complimentary skills in healthcare management

• Provides allergy and dermatology services in primary care practice settings

• Delivers high quality, safe and effective allergy testing and immunotherapy

• Delivers high quality, safe and effective primary dermatologic services

• Provide custom allergy services to physicians under the direction of a board certified allergist

and clinical staff

• Environmental, Food and Penicillin Testing, Scratch/Prick and Intradermal Testing

• Immunotherapy: Subcutaneous and Sublingual

• Spirometry

• Diagnosis and treatment of a broad range of dermatologic conditions under the direction of a

board certified dermatologist and clinical staff

• Biopsy, excision and treatment of benign and premalignant and malignant skin lesions

• Diagnosis and Treatment of chronic skin conditions

• Cosmetic Skin treatments including chemical peels and BotoxR

Key Pillars

Allergy Services

Dermatology

Services

Team

3


Confidential

SACA Executive Team

Team

Allergy

Services

Dermatology

Services

Richard C. WrightPresident

Scott SumrallExecutive Vice President

Abdul IbrahimExecutive Vice President

• 35+ years healthcare

management and transaction

experience

• Highly recognized and

experienced acute and

outpatient acquisitions

specialist

• Lead on UHS acute care

transactions, development,

acquisitions, divestures and

strategic planning

• American Medicorp leadership

and development for 8 years

prior to UHS

• Extensive experience in facilities

development and outpatient

services

• Co-founded Texscan MRI, which

provided outpatient imaging

services throughout Texas

• Regional Director of Imaging

Services for Image America

• Regional Sales Director for

Dominion Diagnostics

• 35+ years of professional

experience in the diagnosis and

treatment of allergies and

asthma

• More than 10 years of clinical

trials and study research in the

areas of allergy, asthma and

immune related diseases

• Director of Clinical Trials

Department ENT & Allergy

Specialists

• Internationally published

4


Confidential

SACA Executive Team

Ryan Sullivan, MDMedical Director

Richard Becker, MDSenior Advisor

Ben Hayes, MD PhDSenior Medical Advisor

• Fellowship in Allergy, Asthma

and Immunology at the

University of Kansas

• Board certified by the American

Board of Internal Medicine as

well as the American Board of

Allergy and Immunology

• Member of the American

Academy of Allergy, Asthma,

and Immunology and of the

American College of Allergy,

Asthma, and Immunology

• 25+ years of medical leadership

and clinical experience

• Former CEO of The George

Washington University Hospital

and The Brooklyn Hospital

Center

• Senior healthcare investment

advisor to multiple private

equity firms

• Board certified in

Anesthesiology and Critical Care

Medicine

• 20+ years of experience in

dermatology and

dermatopathology

• Co-Founder of the Skin & Allergy

Center, a team based clinical

provider of dermatologic and

allergy care in Tennessee

• Board certified in Dermatology

and Dermatopathology

• PhD in Pharmacology

& Immunotoxicology

• Adjunct Clinical Instructor with

Vanderbilt Dermatology

Residency Program

5


Confidential

Our MissionCreate easy access to high quality allergy and dermatology services

Allergy

Services

• Family Practice, Internal Medicine, Pediatrics, General ENT, Pulmonary Medicine

• Multi-provider (5+ including NP’s and PA’s) independent practices

• Acute care hospitals and health care systems

• Rural and Critical Access hospitals

• Reduce skin disease burden and improve outcomes with more active diagnosis and treatment

of skin conditions

• Improve dermatological access for current patient population with fewer outside referrals

• Allow primary care providers to see more patients and increase current patient population

• Produce excellent patient, physician and staff satisfaction

• Provide additional revenue to primary care practices

6

• ASA provides complete, high quality allergy diagnostics and treatment services

• Over 10,000 patients tested, 45,000 treatments administered and 1,200 active immunotherapy

patients in 2016

• Excellent patient, physician and staff satisfaction with no reported adverse or symptomatic

reactions

• Provides growth and additional revenue to physician practices, with added patient

convenience

Expand Access

to Allergy and

Dermatology

Services

Allergy

Services

Impact

Dermatology

Services

Impact


Confidential

SACA Business Model OverviewOur turnkey process provides swift and seamless development

of allergy and dermatology services within primary care settings

Allergy

Services

7

• Physicians complete a practice analysis form located on SACA website (www.asallc.net)

• SACA develops provider proforma

• Provider enters into Provider Services Agreement (PSA) with SACA

• Provider allocates space, certain equipment and supplies

• Provider ensures internet and phone access and connectivity

• ICD 10 analysis for allergy and dermatology related codes in existing practice

• Provide SACA with EHR access

Initial ProcessInitial Process


Confidential

SACA Business Model Overview

Consolidated Allergy and Dermatology Services Proforma*

Allergy

Services

8

�A� FEB �ARCH APRI �AY �U�E �U Y AUGUST SEPT �CT ��V DEC YEAR T�TA

REVE�UE

Dermatology Revenue $53,546 $49,486 $55,576 $53,546 $55,576 $53,546 $53,546 $57,606 $49,486 $55,576 $51,516 $51,516 $640,522

Pathology Revenue $26,922 $24,358 $28,204 $26,922 $28,204 $26,922 $26,922 $29,486 $24,358 $28,204 $25,640 $15,110 $311,252

Allergy Revenue $20,423 $24,188 $35,068 $41,505 $49,134 $55,571 $62,593 $70,719 $73,320 $84,178 $90,030 $97,074 $704,327

T�ta� Reve�ue $100,891 $98,032 $118,848 $121,973 $132,914 $136,039 $143,061 $157,811 $147,164 $167,958 $167,186 $163,700 $1,656,101

EXPE�SE

SACA Expeses & Fees $82,805 $82,805 $82,805 $82,805 $82,805 $82,805 $82,805 $82,805 $82,805 $82,805 $82,805 $82,805 $993,660

H�SPITA �ARGI� $18,086 $15,227 $36,043 $39,168 $50,109 $53,234 $60,256 $75,006 $64,359 $85,153 $84,381 $80,895 $662,441

*Revenues and Expenses based upon projected targets based upon current knowledge of existing practice and is subject to revision during due diligence phase

**SACA Expenses and Fees include Allergy & Dermatology Medical Directors, Nurse Practioner/Physician Assistants, Medical Technicians, Medical Supply, Travel, Training, Education, Furniture, Equipment, IT, Miscellaneous

Operating Expenses and Corporate Overhead


Confidential

SACA Allergy Services Business Model Overview

Comprehensive lab commissioning process initiates safe and efficient delivery of allergy services

Allergy

Services

9

Commissioning the

Allergy Lab

Commissioning the

Allergy Lab

• Lab is commissioned under physician license, and SACA performs services under

the physician’s license


• SACA recruits and provides training to allergy technician and providers

• SACA purchases antigens, medical supplies and minor equipment

• SACA provides policies, procedures and protocols to ensure safety, sanitation,

sterilization and compliance

• SACA delivers all process materials (blue sheets / symptom identification forms)

for circulation to patients in advance of patient/provider encounter


Confidential

SACA Allergy Services Business Model OverviewWe operate high quality allergy labs that precisely follow established, accepted national protocols

Allergy

Services

10

Operating the

Allergy Lab

Operating the

Allergy Lab

• Physician refers patient for allergy consultation

• SACA trained allergy technician evaluates patient and performs appropriate testing

• Clinical director reviews test results and develops specific treatment recommendations

• Provider reviews and approves treatment recommendations

• SACA’s allergy lab prepares customized immunotherapy treatment

• After full patient consent obtained, allergy tech administers treatment as prescribed by

physician

• Allergy tech performs all documentation and posts to SACA and physician practice EHR

• SACA completes ”superbill” and transmits to physician practice business office for

processing

• Provider bills and collects for services rendered; SACA bills fee per procedure

• Provider retains operating profit from delivery of allergy diagnostic and treatment

services


Confidential

SACA Allergy Services Clinical ApproachInitial patient evaluation ensures proper identification of candidates for immunotherapy

Allergy

Services

11

Thorough and

Efficient Clinical

Process

Thorough and

Efficient Clinical

Process

• Provider performs an initial ENT evaluation, including review of systems

• Provider refers appropriate patients for allergy consultations

• Allergy Technician performs Spirometry, Scratch/Prick Test and Intradermal Test

• Clinical Director determines if patient is a candidate for immunotherapy and then

prepares a prescription for physician approval

• Compliant with AAAAI & ACAAI protocols


Confidential

SACA Allergy Services Clinical Approach

Symptom/Syndrome identification process is consistent with the highest practice standards

12

ICD-10 searchPhysical ExaminationPatient History and

Review of Systems Form

• Sneezing

• Runny nose

• Itchy nose

• Post nasal drip

• Stuffy nose

• Redness of the eye

• Redness of the inner eyelid

• Increased amount of tearing

• Itchy eyes

• Swelling of the eyelid

• Cough

• Shortness of breath

• Chest tightness

• Wheezing

Common Asthma SymptomsConjunctivitisSymptoms


Confidential

SACA Allergy Services Business Model DevelopmentComplete Medical Practice and Payor Analysis Ensures Success from the Beginning

Allergy

Services

13

Physica� Exa&i�ati��Patie�t Hist�ry a�d

Review �f Syste&s F�r&• SACA utilizes existing practice data to develop annualized projections for allergy services

• SACA proforma analysis will include revenue, expense and profit projections based upon existing

practice data

95004(Allergy Prick Test)

95024(Intradermal

Injection)

95165(Immunotherapy 1 year)

94010(Spirometry)

BCBS

UHC

Humana

Aetna

Cigna

Medicaid

Medicare

Other:


Confidential

SACA Allergy Services Business Model DevelopmentSample fee schedule illustrates typical procedure and treatment reimbursements

14

Physica� Exa&i�ati��Common CPT Codes and Sample Reimbursements

CPT

Code

Procedure

Description

Total

Units

Unit

Reimbursement

Total Payor

Reimbursement

95004 Allergy Prick Test 40 $6.26 $250.40

95024 Intradermal 35 $7.25 $253.75

95165 Immunotherapy 1 year 300 $12.00 $3600.00

94010 Spirometry 1 $39.50 $39.50

95115 Injection single 1 $8.17 $8.17

95117 Injection (Multi) 1 $9.48 $9.48

• Sublingual Immunotherapy (SLIT) is typically $900/yr and is not typically reimbursed by payors.

• SACA offers annual, semiannual and quarterly payment plans SLIT patient convenience


Confidential

SACA Allergy Services Business Model Development

Sample billing analysis—SACA provides constant oversite of billing and payor complexities*

Allergy

Services

15

Physica� Exa&i�ati��

*Insurance schedules have changed to periodic billing each month as illustrated above

Insurance

Provider

Max Billable

Units Yr 1

Max Billable

Units Yrs 2-5

Number of

Claims per Yr

Frequency of

Claims

Units per

Claim

Additional

Claim

Instructions

AETNA 120 120 1 1 120 0 Bill 120 units x1 each year

BCBS 300 300 10 1/Month 30 0 Up to 60 units every 2 months

CIGNA 120 120 1 1 120 0 2-5 yrs, 84 units 1st month and 36 units next month

HUMANA 300 300 1 1 300 0 100 units/month x 3 consecutive months

MEDICARE 20 & 30

Monthly

20-30 Clinics typically bill 30 units each month

TRICARE 300 300 3 1/Quarter 100/claim 0 100 units per quarter

UHC 300 300 4 1/Month 75/claim 75 Bill 75 units/month x 4 months until 300 units

reached

MEDICAID 160 160 1 1 160/claim 0 Bill 160 units in 1 claim per year

ALL OTHER 300 300 1 1 300 0 Bill 300 units in one claim





CPT Code 95165 Billing Frequency


Confidential

SACA Allergy Services Business Model Development

Sample Practice Proforma demonstrates significant long term practice revenue enhancement*

Allergy

Services

16

Physica� Exa&i�ati��Patie�t Hist�ry a�d

Review �f Syste&s F�r&

REVE�UE �A� FEB �ARCH APRI �AY �U�E �U Y AUGUST SEPT �CT ��V DEC T�TA

CPT

Code Days/Month 21 19 22 21 22 21 21 23 19 22 20 20

95004 Prick Test $4,956 $4,484 $5,192 $4,956 $5,192 $4,956 $4,956 $5,428 $4,484 $5,192 $4,720 $4,720 $59,236

95024 Intradermal $6,048 $3,325 $6,336 $6,048 $6,336 $6,048 $6,048 $6,624 $3,325 $6,336 $5,760 $5,760 $67,994

95165 SCITS** $8,160 $14,720 $21,280 $27,840 $34,400 $40,960 $47,520 $54,080.00 $60,640 $67,200 $73,760 $80,320 $530,880

94010 Spirometry $735 $665 $770 $735 $735 $735 $735 $805 $665 $770 $700 $700 $8,785

95117 Muti Injection $260 $540 $826 $1,086 $1,385 $1,645 $1,918 $2,178 $2,438 $2,698 $2,958 $3,218 $21,150

95115 Single Injection $180 $378 $576 $756 $963 $1,143 $1,332 $1,512 $1,692 $1,872 $2,052 $2,232 $14,688

TOTAL REVENUE $20,339 $24,112 $34,980 $41,421 $49,046 $55,487 $62,509 $70,627 $73,244 $84,068 $89,950 $96,950 $702,733

EXPE�SES �A� FEB �ARCH APRI �AY �U�E �U Y AUGUST SEPT �CT ��V DEC T�TA

95004 Pric2 Test $3�990 $3�610 $4�180 $3�990 $4�180 $3�990 $3�990 $4�370 $3�610 $4�180 $3�800 $3�800 $47�690

95024 I�trader&a� $3�675 $3�325 $3�850 $3�675 $3�850 $3�675 $3�675 $4�025 $3�325 $3�850 $3�500 $3�500 $43�925

95165 SCITS $3,672 $6,624 $9,576 $12,528 $15,480 $18,432 $21,384 $24,336 $27,288 $30,240 $33,192 $36,144 $238,896

94010 Spir�&etry $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0

95117 �uti I�4ecti�� $120 $252 $384 $504 $642 $762 $888 $1,008 $1,128 $1,248 $1,368 $1,488 $9,792

95115 Si�g�e I�4ecti�� $80 $168 $256 $336 $428 $508 $592 $672 $752 $832 $912 $992 $6,528

T�TA EXPE�SE $11,537 $13,979 $18,246 $21,033 $24,580 $27,367 $30,529 $34,411 $36,103 $40,350 $42,772 $45,924 $346,831

PRACTICE �ET �ARGI� $8,802 $10,133 $16,734 $19,729 $24,466 $28,120 $31,980 $36,216 $37,141 $43,718 $47,178 $51,026 $355,902

* Actual revenue and net margin dependent on case volume, payor reimbursement rates and actual expenses

**95165 (SCITS) revenues continue to compound each month as compliant patients are added


Confidential

SACA Allergy Services Summary

Provides access to modern, high quality allergy diagnostic and treatment

services, improves patient satisfaction and enhances physician practice revenue

Allergy

Services

17

ASA 6 Physicia�

part�erships

a�ig�ed f�r

&utua� be�efit

ASA 6 Physicia�

part�erships

a�ig�ed f�r

&utua� be�efit

• Respond to the growing shortage of allergists, SACA provides real time diagnosis and allergy

treatment services for primary care practices

• Convenience and control of treatment with program administered under the direction of a

Board Certified Allergist with testing performed by qualified Allergy Technicians

• SACA’s turnkey approach expands primary care services while often improving practice

efficiency

• SACA business model provides practice with significantly increased ancillary revenue


Confidential

SACA Dermatology ServicesSignificant concern around high incidence of dermatologic

conditions, including skin cancers, across populations

Team

Allergy

Services

Dermatology

Services

General

Prevalence1

Incidence and

Gender1

Incidence and

Gender1

Incidence and

Ethnicity1

Incidence and

Ethnicity1

• Skin cancer is the most common cancer in the United States and is the primary driver for demand of

dermatology services

• In the U.S., approximately one in five people will develop skin cancer in their lifetime with nearly 9,500 newly

diagnosed skin cancers every day

• Melanoma rates in the United States doubled from 1982 to 2011 with estimates that 161,790 new cases of

melanoma, 74,680 noninvasive (in situ) and 87,110 invasive, will be diagnosed in the U.S. in 2017

• 5.4 million cases of nonmelanoma skin cancer (NMSC), including basal cell carcinoma and squamous cell

carcinoma, were treated in 3.3 million people in the United States in 2012

• The overall incidence of BCC increased by 145 percent between 1976-1984 and 2000-2010, and the overall

incidence of SCC increased 263 percent over that same period with significant rises in people younger than 40

• Invasive melanoma is projected to be 5th most common male cancer and 6th most common female cancer in 2017

• Melanoma is the second most common form of cancer in females age 15-29 and is increasing faster in females

age 15-29 than in same aged males.

• Before age 50, melanoma incidence rates are higher in women than in men, but by age 65, rates are twice as high

in men

• Women had the greatest increase in incidence for both types of NMSC, but the incidence in men ages 80 and

older is 3x higher than same aged women

• Caucasians and men older than 50 have a higher risk of developing melanoma than the general population

• The annual incidence rate of melanoma in non-Hispanic Caucasians is 26 per 100,000, compared to 5 per

100,000 in Hispanics and 1 per 100,000 in African-Americans

• In people of color, melanoma is often diagnosed at later stages, when the disease is more advanced

• Melanoma in Caucasian women younger than 44 has increased 6.1 percent annually, which may reflect

recent trends in indoor tanning

18


Confidential

High Demand for Dermatology ServicesAccess Issues and Increasing Costs

Team

Allergy

Services

Dermatology

Services

General Access

to Dermatology

Services1

Cost Impact of

Dermatologic

Conditions1

• There are fewer than 10,000 licensed dermatologists in the U.S., or 3.4 per 100,000

population, significantly below the recommended minimum of 4.0 per 100,000

• The distribution of dermatologists is skewed towards more densely populated, affluent

urban areas and away from economically challenged urban or rural geographies

• There is a current shortage of dermatologists that is expected to persist for the

foreseeable future

• Increasing demand for dermatology services driven primarily by rising occurrence of skin

cancer and the aging of the population.

• About 4.9 million U.S. adults were treated for skin cancer each year from 2007 to 2011, for

an average annual treatment cost of $8.1 billion

• This represents an increase over the period from 2002 to 2006, when about 3.4 million

adults were treated for skin cancer each year, for an annual average treatment cost of $3.6

billion

• The annual cost of treating nonmelanoma skin cancer (NMSC) in the U.S. is estimated at

$4.8 billion, while the average annual cost of treating melanoma is estimated at $3.3 billion

19


Confidential

SACA Dermatology Services Clinical Approach Symptom / Syndrome identification is a complete process consistent with the highest physician practice standards

Team

Allergy

Services

Dermatology

Services

• Rash

• Skin growth

• Psoriasis

• Eczema

• Mole checks

• Acne

• Itchy Skin

• New Skin growth

• Mole changing color or shape

• Skin Dryness

• Psoriasis

• Acne

• Eczema

• Pruritis

• Basal Cell Carcinoma

Common CodesSymptomsSigns

Patient History and

Review of Symptoms

20


Confidential

Physical Examination ICD-10 search

SACA Dermatology Services Business Model DevelopmentComplete Medical Practice and Payor Analysis Ensures Success from the Beginning

Team

Allergy

Services

Dermatology

Services

Patient History and Review of Symptoms Form Physical Examination

• SACA utilizes existing practice data to develop annualized projections for dermatology services

• SACA proforma analysis will include revenue, expense and profit projections based upon

existing practice data

Data Sheet: Annual Case Volume for Common Dermatology CPT codes by Payor

99212 99213 99214 17111

BCBS

UHC

Humana

Aetna

Cigna

Medicaid

Medicare

Other:

21


Confidential

SACA Dermatology Services Business Model OverviewTurnkey process brings an increased scope of dermatologic care to physician practices

Team

Allergy

Services

Dermatology

Services

Initial Process

• Physicians complete a practice analysis form located on SACA website (www.asallc.net)

• SACA develops provider proforma

• Provider enters into Provider Services Agreement (PSA) with SACA


• Provider ensures internet and phone access and connectivity

• ICD 10 analysis for dermatology related codes in existing practice

• Provide SACA with EHR access

22


Confidential

SACA Dermatology Services Business Model OverviewWe manage all aspects to initiate safe and efficient delivery of dermatology services

Team

Allergy

Services

Dermatology

Services

Developing the

Dermatology

Service

• SACA performs services under the physician’s license


• SACA recruits and provides training to physicians, and dermatology nurse practitioner

or physician’s assistant

• SACA purchases medical supplies and minor equipment

• SACA provides policies, procedures and protocols to ensure safety, sanitation,

sterilization and compliance

• SACA delivers all process materials (blue sheets / symptom identification forms) for

circulation to patients in advance of patient/provider encounter

23


Confidential

SACA Dermatology Services Business Model OverviewProvides high quality dermatology services that preciselyfollow established and accepted national protocols

Team

Allergy

Services

Dermatology

Services

Operating the

Dermatology

Service

• Physician refers patient for in-house dermatology consultation

• SACA trained dermatology mid-level provider (NP or PA) evaluates patient

• Dermatology NP, with oversight from board certified dermatologist, develops specific treatment recommendations

• After full patient consent obtained, dermatology mid-level provider performs treatment (prescription, cryosurgery, biopsy, surgery)

• Biopsy material sent to SACA dermatopathologist for microscopic analysis and definitive findings

• Dermatology mid-level provider and physician receive pathology result, communicate with patient and schedule follow up visit as needed.

• Dermatology mid-level provider performs all documentation and posts to SACA and physician practice EHR

• SACA completes ”superbill” and transmits to physician practice business office for processing

• Provider bills and collects for services rendered; SACA bills fee per procedure

• Provider retains operating profit from delivery of dermatology diagnostic and treatment services

24


Confidential

SACA Dermatology Services Clinical ApproachInitial patient evaluation ensures proper identification of candidates for additional dermatology consultation

Team

Allergy

Services

Dermatology

Services

Thorough and

Efficient Clinical

Process

• Primary Care Physician (PCP) performs an initial dermatologic evaluation

• Patient referred to dermatology mid-level provider for further evaluation and

treatment

• Dermatology mid-level provider performs detailed evaluation and confers as needed

with SACA’s Board Certified Dermatologists via telehealth connection

• Appropriate treatments include prescription medication, incisional or excisional

biopsy are performed with proper consents and disclosures

• All biopsy specimens submitted for review and analysis by Board Certified

Dermatopathologist

• Results returned to PCP and discussed, as appropriate, between PCP, patient and

dermatology providers

• Patient and PCP determine next steps, including additional consultation as needed

• Compliant with best of practice dermatology protocols

25


Confidential

SACA Dermatology Services Business Model DevelopmentSample fee schedule illustrates typical procedure and treatment reimbursements

Team Physical ExaminationCommon CPT Codes and Sample Reimbursements

CPT

Code

Procedure

Description

Total

Units

Net

Reimbursement

11100 Skin biopsy 1 $46.97

11101 Additional biopsy 1 $22.72

17000 Cryosurgery, precancer x 1 1 $50.21

17004 Cryosurgery, precancer > 14 1 $94.74

17110 Cryosurgery, benign x 1 1 $65.90

17114 Cryosurgery benign > 15 1 $81.19

26


Confidential

SACA Dermatology Services Business Model DevelopmentSample Practice Proforma demonstrates significant long term practice revenue enhancement*

Physical Examination ICD-10 search

Business Model Development (DEVELOP DERM PROFORMA)Sample Practice Proforma demonstrates significant

long term practice revenue enhancement*

* Actual revenue and net margin dependent on case volume, payor reimbursement rates and actual expenses

27

��th �a�uary February �arch Apri� �ay �u�e �u�y August Sept �ct�ber ��v Dec YTD T�ta�s

CPT C�de Reveue 21 days 19 days 22 days 21 days 22 days 21 days 21 days 23 days 19 days 22 days 20 days 20 days

Der&

99213 $95 $15�960 $14�440 $16�720 $15�960 $16�720 $15�960 $15�960 $17�480 $14�440 $16�720 $15�200 $15�200 $190�760

99212 $95 $7�980 $7�220 $8�360 $7�980 $8�360 $7�980 $7�980 $8�740 $7�220 $8�360 $7�600 $7�600 $95�380

99214 $95 $5�985 $5�415 $6�270 $5�985 $6�270 $5�985 $5�985 $6�555 $5�415 $6�270 $5�700 $5�700 $71�535

17000 $85 $8�925 $8�075 $9�350 $8�925 $9�350 $8�925 $8�925 $9�775 $8�075 $9�350 $8�500 $8�500 $106�675

17003 $12 $96 $96 $96 $96 $96 $96 $96 $96 $96 $96 $96 $96 $1�152

17004 $180 $1�440 $1�440 $1�440 $1�440 $1�440 $1�440 $1�440 $1�440 $1�440 $1�440 $1�440 $1�440 $17�280

17110 $181 $1�448 $1�448 $1�448 $1�448 $1�448 $1�448 $1�448 $1�448 $1�448 $1�448 $1�448 $1�448 $17�376

17111 $80 $1�680 $1�520 $1�760 $1�680 $1�760 $1�680 $1�680 $1�840 $1�520 $1�760 $1�600 $1�600 $20�080

17261 $185 $1�480 $1�480 $1�480 $1�480 $1�480 $1�480 $1�480 $1�480 $1�480 $1�480 $1�480 $1�480 $17�760

11100 $171 $1�368 $1�368 $1�368 $1�368 $1�368 $1�368 $1�368 $1�368 $1�368 $1�368 $1�368 $1�368 $16�416

11101 $56 $840 $840 $840 $840 $840 $840 $840 $840 $840 $840 $840 $840 $10�080

11300 $112 $672 $672 $672 $672 $672 $672 $672 $672 $672 $672 $672 $672 $8�064

11301 $155 $930 $930 $930 $930 $930 $930 $930 $930 $930 $930 $930 $930 $11�160

11401 $100 $800 $800 $800 $800 $800 $800 $800 $800 $800 $800 $800 $800 $9�600

11602 $150 $1�200 $1�200 $1�200 $1�200 $1�200 $1�200 $1�200 $1�200 $1�200 $1�200 $1�200 $1�200 $14�400

96910 $107 $642 $642 $642 $642 $642 $642 $642 $642 $642 $642 $642 $642 $7�704 C�s#etic che#ica( pee( $100 $2�100 $1�900 $2�200 $2�100 $2�200 $2�100 $2�100 $2�300 $1�900 $2�200 $2�000 $2�000 $25�100

Subt�ta�$51,446 $47,586 $53,376 $51,446 $53,376 $51,446 $51,446 $55,306 $47,586 $53,376 $49,516 $49,516 $640,522

Path

88304 $38 $798 $722 $836 $798 $836 $798 $798 $874 $722 $836 $760 $760 $9�538

88305 $65 $12�285 $11�115 $12�870 $12�285 $12�870 $12�285 $12�285 $13�455 $11�115 $12�870 $11�700 $1�170 $136�305

88341 $88 $3�696 $3�344 $3�872 $3�696 $3�872 $3�696 $3�696 $4�048 $3�344 $3�872 $3�520 $3�520 $44�176 88342 $100 $6�300 $5�700 $6�600 $6�300 $6�600 $6�300 $6�300 $6�900 $5�700 $6�600 $6�000 $6�000 $75�300

88313 $61 $3�843 $3�477 $4�026 $3�843 $4�026 $3�843 $3�843 $4�209 $3�477 $4�026 $3�660 $3�660 $45�933

Subt�ta� $26,922 $24,358 $28,204 $26,922 $28,204 $26,922 $26,922 $29,486 $24,358 $28,204 $25,640 $15,110 $311,252 T�TA

REVE�UE $78,368 $71,944 $81,580 $78,368 $81,580 $78,368 $78,368 $84,792 $71,944 $81,580 $75,156 $64,626 $951,774 SACA

Expense

& Fees $47,021 $43,166 $48,948 $47,021 $48,948 $47,021 $47,021 $50,875 $43,166 $48,948 $45,094 $38,776 $571,064 HOSPITAL

MARGIN $31,347 $28,778 $32,632 $31,347 $32,632 $31,347 $31,347 $33,917 $28,778 $32,632 $30,062 $25,850 $380,710


Confidential

SACA Dermatology Services SummarySkin and Allergy Centers of America provides access to modern, high quality

dermatology services, improves patient satisfaction and enhances physician practice revenue

Team

Allergy

Services

SACA / Physician

partnerships aligned

for mutual benefit

• Respond to the growing shortage of dermatologists, SACA provides real time

dermatology services for primary care practices

• Convenience and control of treatment with program administered under the

direction of a Board Certified Dermatologist with testing performed by

qualified Dermatology trained mid-level provider

• SACA’s turnkey approach expands primary care services while often improving

practice efficiency

• SACA business model provides practice with significantly increased ancillary

revenue

28


Confidential

Contact Information

Richard C. Wright Scott Sumrall Abdul Ibrahim

President

(919) 240-7556

[email protected]

Executive Vice President

(214) 384-9013

[email protected]

Executive Vice President

(484)995-5019

[email protected]

Ryan Sullivan, MD Phylly Arnold

Medical Director

(615) 585-5549

[email protected]

Senior Advisor

(347) 852-3664

[email protected]

Director, Business Development

(817) 917-7896

[email protected]

29


Confidential

Richard Becker, MD

expanded clinical service options for physician practices allergy … derm allergy handouts...

Documents